Evaluating Endometriosis With 16α-(18)F-fluoro-17β-estradiol ([F-18] FES) PET/MRI
NCT04347135 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL
Last updated 2024-05-10
Summary
Researchers are trying to improve the detection of endometriosis using F-18 FES PET/MRI imaging.
Conditions
- Endometriosis
Interventions
- DRUG
-
F-18 FES
F-18 FES PET/MRI for detection of endometriosis.
Sponsors & Collaborators
-
Annie (Annie) T. Packard
lead OTHER
Principal Investigators
-
Ann Packard, MD · Mayo Clinic
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-07
- Primary Completion
- 2024-04-30
- Completion
- 2024-04-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Use of a New Diagnostic Tool in the Detection and Characterization of Endometriosis Lesions
NCT07053982 ·Status: RECRUITING ·Phase: NA
-
Contribution of PET (Positron Emission Tomography) Scans for the Preoperative Assessment of Symptomatic Endometriosis Lesions: TEP-ENDORUN
NCT04831619 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Endometrial Scratch Prior to Frozen Embryo Transfer in Patients With Recurrent Implantation Failure
NCT03157765 ·Status: WITHDRAWN ·Phase: NA
-
Feasibility Study of Using Molecular Fluorescence Guided Surgery in Endometriosis
NCT02975219 ·Status: UNKNOWN ·Phase: PHASE1
-
18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy
NCT05483023 ·Status: WITHDRAWN ·Phase: PHASE2
-
Preoperative Staging of Endometriosis With MRI
NCT01939535 ·Status: COMPLETED
-
Developing an US-MRI Biomarker Fusion Model for Endometriosis
NCT04974710 ·Status: COMPLETED
-
ENDOMED: Evaluation of the Evolution of Endometriosis Lesions on Imaging Under Medical Treatment
NCT05722314 ·Status: UNKNOWN
-
Effects of Varied Estrogen Doses on Endometrial Receptivity
NCT02458404 ·Status: COMPLETED
-
Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation
NCT00999479 ·Status: WITHDRAWN ·Phase: NA
-
Oxytocin in MRI-HIFU
NCT03937401 ·Status: UNKNOWN ·Phase: PHASE4
-
Value of Advanced MRI Techniques in the Assessment of Endometriosis
NCT06481982 ·Status: WITHDRAWN
-
The Effect of Endometrial Scratching on Patients With Endometriosis
NCT05360875 ·Status: UNKNOWN ·Phase: NA
-
Endometriosis Impact on Oocyte Quality
NCT03241329 ·Status: COMPLETED
-
Endometriosis: Immunomodulation
NCT01184144 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Endometrial and Myometrial Changes, With and Without Fibroids
NCT01671215 ·Status: WITHDRAWN
-
Physiotherapy of the Pelvic Floor in Women With Deep Infiltrating Endometriosis
NCT03572075 ·Status: UNKNOWN ·Phase: NA
-
Risk Factors and Disorders Linked to Uterine Adenomyosis on MRI in Reproductive-Age Women
NCT06697444 ·Status: COMPLETED
-
Antilipidemic Ezetimibe Induces Regression of Endometriotic Explants in a Rat Model of Endometriosis
NCT04844996 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Diagnosis of Pelvic Endometriosis in MRI
NCT06157528 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment
NCT06279195 ·Status: WITHDRAWN ·Phase: PHASE2
-
Endometrial Biopsy Prior to IVF in Those Patients With Prior Implantation Failure
NCT01800513 ·Status: UNKNOWN ·Phase: NA
-
Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU)
NCT02914704 ·Status: RECRUITING ·Phase: NA
-
Microbiome and Immunologic Analysis - Women With Endometriosis
NCT04159740 ·Status: COMPLETED
-
Ovariopexy for Adhesion Prevention After Laparoscopic Removal of Endometriosis of the Pelvic Side Wall or the Ovary
NCT04669756 ·Status: COMPLETED ·Phase: NA